Denosumab in transfusion-dependent thalassemia osteoporosis: a randomized, placebo-controlled, double-blind phase 2b clinical trial.
Saved in:
| Title: | Denosumab in transfusion-dependent thalassemia osteoporosis: a randomized, placebo-controlled, double-blind phase 2b clinical trial. |
|---|---|
| Authors: | Voskaridou E; Thalassemia and Sickle Cell Disease Center, 'Laiko' General Hospital, Athens, Greece., Ntanasis-Stathopoulos I; Department of Clinical Therapeutics and., Papaefstathiou A; Endocrine Unit, Second Department of Internal Medicine-Propaedeutic, Research Institute and Diabetes Center, National and Kapodistrian University of Athens School of Medicine, Athens, Greece; and., Christoulas D; Department of Hematology and., Dimopoulou M; Thalassemia and Sickle Cell Disease Center, 'Laiko' General Hospital, Athens, Greece., Repa K; Thalassemia and Sickle Cell Disease Center, 'Laiko' General Hospital, Athens, Greece., Papatheodorou A; Department of Biomedical Research, 251 General Air-Force Hospital, Athens, Greece., Peppa M; Endocrine Unit, Second Department of Internal Medicine-Propaedeutic, Research Institute and Diabetes Center, National and Kapodistrian University of Athens School of Medicine, Athens, Greece; and., Terpos E; Department of Clinical Therapeutics and. |
| Source: | Blood advances [Blood Adv] 2018 Nov 13; Vol. 2 (21), pp. 2837-2847. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30381400 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Denosumab in transfusion-dependent thalassemia osteoporosis: a randomized, placebo-controlled, double-blind phase 2b clinical trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Voskaridou+E%22">Voskaridou E</searchLink>; Thalassemia and Sickle Cell Disease Center, 'Laiko' General Hospital, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Ntanasis-Stathopoulos+I%22">Ntanasis-Stathopoulos I</searchLink>; Department of Clinical Therapeutics and.<br /><searchLink fieldCode="AU" term="%22Papaefstathiou+A%22">Papaefstathiou A</searchLink>; Endocrine Unit, Second Department of Internal Medicine-Propaedeutic, Research Institute and Diabetes Center, National and Kapodistrian University of Athens School of Medicine, Athens, Greece; and.<br /><searchLink fieldCode="AU" term="%22Christoulas+D%22">Christoulas D</searchLink>; Department of Hematology and.<br /><searchLink fieldCode="AU" term="%22Dimopoulou+M%22">Dimopoulou M</searchLink>; Thalassemia and Sickle Cell Disease Center, 'Laiko' General Hospital, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Repa+K%22">Repa K</searchLink>; Thalassemia and Sickle Cell Disease Center, 'Laiko' General Hospital, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Papatheodorou+A%22">Papatheodorou A</searchLink>; Department of Biomedical Research, 251 General Air-Force Hospital, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Peppa+M%22">Peppa M</searchLink>; Endocrine Unit, Second Department of Internal Medicine-Propaedeutic, Research Institute and Diabetes Center, National and Kapodistrian University of Athens School of Medicine, Athens, Greece; and.<br /><searchLink fieldCode="AU" term="%22Terpos+E%22">Terpos E</searchLink>; Department of Clinical Therapeutics and. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2018 Nov 13; Vol. 2 (21), pp. 2837-2847. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30381400 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/bloodadvances.2018023085 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2837 Titles: – TitleFull: Denosumab in transfusion-dependent thalassemia osteoporosis: a randomized, placebo-controlled, double-blind phase 2b clinical trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Voskaridou E – PersonEntity: Name: NameFull: Ntanasis-Stathopoulos I – PersonEntity: Name: NameFull: Papaefstathiou A – PersonEntity: Name: NameFull: Christoulas D – PersonEntity: Name: NameFull: Dimopoulou M – PersonEntity: Name: NameFull: Repa K – PersonEntity: Name: NameFull: Papatheodorou A – PersonEntity: Name: NameFull: Peppa M – PersonEntity: Name: NameFull: Terpos E IsPartOfRelationships: – BibEntity: Dates: – D: 13 M: 11 Text: 2018 Nov 13 Type: published Y: 2018 Identifiers: – Type: issn-electronic Value: 2473-9537 Numbering: – Type: volume Value: 2 – Type: issue Value: 21 Titles: – TitleFull: Blood advances Type: main |
| ResultId | 1 |
